Anakinra (brand name Kineret) is a recombinant version of IL-1Ra that is clinically used to treat rheumatoid arthritis, but may have a broader clinical impact in treating solid tumors that have increased IL-1α expression. The gene discussed is IL1A; the disease is rheumatoid arthritis.